NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 195 filers reported holding NEVRO CORP in Q1 2017. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,046,000 | -91.1% | 15,145 | -88.4% | 0.14% | -90.6% |
| Q3 2017 | $11,814,000 | +2.3% | 130,000 | -16.2% | 1.51% | -9.0% |
| Q2 2017 | $11,545,000 | +9.4% | 155,118 | +37.7% | 1.66% | -0.8% |
| Q1 2017 | $10,552,000 | +62.6% | 112,614 | +26.1% | 1.67% | +34.3% |
| Q4 2016 | $6,490,000 | -99.9% | 89,314 | +81.2% | 1.24% | +52.3% |
| Q3 2016 | $5,146,427,000 | +128400.0% | 49,300 | -9.2% | 0.82% | +14.9% |
| Q2 2016 | $4,005,000 | +256.0% | 54,300 | +171.5% | 0.71% | +218.8% |
| Q1 2016 | $1,125,000 | – | 20,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |